Qube Research & Technologies (QRT)’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-9
| Closed | -$6 | – | 4347 |
|
|
2024
Q2 | $6 | Hold |
9
| – | – | ﹤0.01% | 3649 |
|
|
2024
Q1 | $5 | Hold |
9
| – | – | ﹤0.01% | 4334 |
|
|
2023
Q4 | $5 | Sell |
9
-982
| -99% | -$591 | ﹤0.01% | 4212 |
|
|
2023
Q3 | $660 | Buy |
+991
| New | +$1.21K | ﹤0.01% | 3655 |
|
|
2023
Q1 | – | Sell |
-497
| Closed | -$5.83K | – | 3138 |
|
|
2022
Q4 | $5.83K | Sell |
497
-539
| -52% | -$9.51K | ﹤0.01% | 2317 |
|
|
2022
Q3 | $22K | Sell |
1,036
-14,960
| -94% | -$403K | ﹤0.01% | 2284 |
|
|
2022
Q2 | $388K | Buy |
15,996
+13,033
| +440% | +$444K | ﹤0.01% | 1507 |
|
|
2022
Q1 | $148K | Buy |
2,963
+616
| +26% | +$30.4K | ﹤0.01% | 2007 |
|
|
2021
Q4 | $165K | Buy |
2,347
+1,366
| +139% | +$115K | ﹤0.01% | 2030 |
|
|
2021
Q3 | $92K | Sell |
981
-1,538
| -61% | -$146K | ﹤0.01% | 1807 |
|
|
2021
Q2 | $253K | Buy |
+2,519
| New | +$246K | ﹤0.01% | 1678 |
|
|
2020
Q4 | – | Sell |
-3,745
| Closed | -$321K | – | 2291 |
|
|
2020
Q3 | $321K | Buy |
+3,745
| New | +$436K | ﹤0.01% | 1216 |
|
Qube Research & Technologies (QRT)'s VBIV Position: Q3 2024 in Review
Qube Research & Technologies (QRT) sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2024, closing a stake of 9 shares — an estimated $6 sold.
Qube Research & Technologies (QRT) first reported a position in VBIV in Q3 2020 and held it in 12 quarters. The position peaked at $388K in Q2 2022. 1 fund tracked by Wall St. Rank holds VBIV as of Q3 2024.
- Qube Research & Technologies (QRT) reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2024 after selling out during the quarter.
- Qube Research & Technologies (QRT) sold 9 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2024, an estimated $6.
- Qube Research & Technologies (QRT) first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q3 2020 and held it in 12 quarters.
- Qube Research & Technologies (QRT)'s VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $388K in Q2 2022.
- 1 fund tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2024.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.